“…In 21 patients treated with this regimen, the OR rate was 57% with 3 complete responders (14%). 224 CVP (cyclophosphamide, vincristine, prednisone), CVPB (cyclophosphamide, vincristine, prednisone, and bleomycin), and CHOP (cyclophosphamide, adriamycin, vincristine, and prednisone) have also been effective in MF. 225,226 In 1998, Hallahan et al treated patients with T3 stage MF with TSBEB and MOPP (methotrexate, vincristine, procarbazine, prednisone) or COPP (cyclophosphamide, vincristine, procarbazine, prednisone) and reported a 70% OR rate and 14 month duration of response.…”